Editorial: COVID and psychotropics 2024: lessons learnt and future directions for research
Frontiers in Psychiatry · 03.03.2026 · 17
DOI: 10.3389/fpsyt.2026.1800334 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Psychiatry, online erschienen am 03.03.2026. Verfasst von Patricia Di Ciano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada.
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
- Campbell Family Mental Health Research Institute, Toronto, ON, Canada.
- Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia.
- Ramat-Chen Brüll Mental Health Center, Tel-Aviv District, Clalit Health Services Community Division, Tel Aviv, Israel.
Zitieren
APA
Di Ciano, P., Das, S., Toren, P., & Scherbaum, N. (2026). Editorial: COVID and psychotropics 2024: lessons learnt and future directions for research. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1800334
Vancouver
Di Ciano P, Das S, Toren P, Scherbaum N. Editorial: COVID and psychotropics 2024: lessons learnt and future directions for research. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1800334
BibTeX
@article{DiCiano2026,
author = {Di Ciano, Patricia and Das, Soumitra and Toren, Paz and Scherbaum, Norbert},
title = {Editorial: COVID and psychotropics 2024: lessons learnt and future directions for research},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1800334}
}
EUVIMED